Agarwal Sunil
EVP, Head of Development & CMO at SANA; President of R & D at Juno Therapeutics, Inc.; Chief Medical Officer at RARE
- Sold, on record
- $4.3M
- Dollars the filings state
- Form 4 sales
- 14
- Latest Sep 16, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- SANASana Biotechnology, Inc.EVP, Head of Development & CMO
- Juno Therapeutics, Inc.President of R & D
- RAREUltragenyx Pharmaceutical Inc.Chief Medical Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- SANA60,000 shares
- RARE23,654 shares
- Juno Therapeutics, Inc.7,285 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale RAREPlan not statedFeb 22 2016
Sold 658 shares at $63.48 ($42k)
Agarwal Sunil, Chief Medical Officer
Sold 5.8% of holdings ($718k position)10,650 shares left1.2x usual sizeFiling
- 2 Form 4 sale RAREPlan not statedMar 22 +29 days
Sold 650 shares at $61.45 ($40k)
Agarwal Sunil, Chief Medical Officer
Sold 6.3% of holdings ($630k position)9,608 shares left1.1x usual sizeFiling
- 3 Form 4 sale RAREPlan not statedApr 20 +29 days
Sold 649 shares at $70.53 ($46k)
Agarwal Sunil, Chief Medical Officer
Sold 7% of holdings ($650k position)8,567 shares left1.1x usual sizeFiling
- 4 Form 4 sale RAREPlan not statedMay 24 +34 days
Sold 650 shares at $66.00 ($43k)
Agarwal Sunil, Chief Medical Officer
Sold 8.4% of holdings ($512k position)7,111 shares left1x usual sizeFiling
- 5 Form 4 sale RAREPlan not statedJun 20 +27 days
Sold 650 shares at $54.16 ($35k)
Agarwal Sunil, Chief Medical Officer
Sold 5.8% of holdings ($608k position)10,569 shares left1x usual sizeFiling
- 6 Form 4 sale RAREPlan not statedJul 21 +31 days
Sold 649 shares at $52.68 ($34k)
Agarwal Sunil, Chief Medical Officer
Sold 6.4% of holdings ($536k position)9,528 shares left1x usual sizeFiling
- 7 Form 4 sale Juno Therapeutics, Inc.Plan not statedOct 2 +438 days
Sold 7,285 shares at $44.76 ($326k)
Agarwal Sunil, President of R & D
Sold 7.9% of holdings ($4.1M position)84,549 shares leftFirst sale on recordFiling
- 8 Form 4 sale SANAPlan not statedSep 16 +1445 days
Sold 60,000 shares at $26.07 ($1.6M)
Agarwal Sunil, EVP, Head of Development & CMO
Sold 3.7% of holdings ($42M position)1.6M shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (14)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sep 16, 2021 | SANA | EVP, Head of Development & CMO | Form 4 sale | 60,000 | $1.6M | 3.7% | Plan not stated | SEC |
| Oct 2, 2017 | Juno Therapeutics, Inc. | President of R & D | Form 4 sale | 7,285 | $326k | 7.9% | Plan not stated | SEC |
| Jul 21, 2016 | RARE | Chief Medical Officer | Form 4 sale | 649 | $34k | 6.4% | Plan not stated | SEC |
| Jun 20, 2016 | RARE | Chief Medical Officer | Form 4 sale | 650 | $35k | 5.8% | Plan not stated | SEC |
| May 24, 2016 | RARE | Chief Medical Officer | Form 4 sale | 650 | $43k | 8.4% | Plan not stated | SEC |
| Apr 20, 2016 | RARE | Chief Medical Officer | Form 4 sale | 649 | $46k | 7.0% | Plan not stated | SEC |
| Mar 22, 2016 | RARE | Chief Medical Officer | Form 4 sale | 650 | $40k | 6.3% | Plan not stated | SEC |
| Feb 22, 2016 | RARE | Chief Medical Officer | Form 4 sale | 658 | $42k | 5.8% | Plan not stated | SEC |
| Jan 20, 2016 | RARE | Chief Medical Officer | Form 4 sale | 585 | $43k | 4.6% | Plan not stated | SEC |
| Dec 22, 2015 | RARE | Chief Medical Officer | Form 4 sale | 498 | $57k | 3.6% | Plan not stated | SEC |
| Nov 23, 2015 | RARE | Chief Medical Officer | Form 4 sale | 498 | $48k | 3.5% | Plan not stated | SEC |
| Oct 20, 2015 | RARE | Chief Medical Officer | Form 4 sale | 649 | $55k | 4.2% | Plan not stated | SEC |
| Sep 22, 2015 | RARE | Chief Medical Officer | Form 4 sale | 498 | $55k | 3.0% | Plan not stated | SEC |
| Aug 20, 2015 | RARE | Chief Medical Officer | Form 4 sale | 17,020 | $1.9M | 50.2% | Unusual | SEC |